Ibrutinib Decreases Obinutuzumab-Induced Secretion of Cytokines Associated With Infusion-Related Reactions in Patients With Cll: Analysis From the Illuminate Study

Hematological Oncology - United Kingdom
doi 10.1002/hon.27_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Obinutuzumab Plus Bendamustine in Previously Untreated Patients With CLL: A Subgroup Analysis of the GREEN Study

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

Ongoing Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

High Efficacy of Venetoclax Plus Obinutuzumab in Patients With Complex Karyotype (Ckt) and Chronic Lymphocytic Leukemia (Cll): A Prospective Analysis From the Cll14 Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Infusion Reactions Related to Infliximab Therapy Are Not Usually Associated With Drug Discontinuation

Journal of Rheumatology
RheumatologyAllergyImmunology
2012English

Bendamustine (B), Followed by Obinutuzumab (G) and Venetoclax (A) in Patients With Chronic Lymphocytic Leukemia (Cll): Cll2-Bag Trial of the German CLL Study Group (Gcllsg)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Significant Weight Gain in CLL Patients Treated With Ibrutinib: A Potentially Deleterious Consequence of Therapy

American Journal of Hematology
Hematology
2019English

Cost-Effectiveness of Ibrutinib in Patients With Relapsed or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Venetoclax–Obinutuzumab Elicits High Response Rates in CLL

Cancer Discovery
Oncology
2019English

Ibrutinib for Relapsed / Refractory Cll: An Update of the Uk and Ireland Analysis of Outcomes in 315 Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy